Four commitments under one roof.
Direct investments, capital partnerships, operating companies, and confidential advisory — held together by the same standard.
Direct Investments
Pierpont invests its own capital directly in growth-oriented private companies. Our history is in corporate roll-ups, market-entry platforms, mergers, joint ventures, alliances, and positioning companies for IPO or strategic sale — and that experience continues to define what we look for.
We are drawn to founder-led and family-owned businesses where operational improvement, disciplined add-on acquisition, and better decision-making create durable value. We hold for as long as the business rewards holding.
Capital Partnerships
Pierpont invests the family’s own capital. It is not our only source of capital. For strategic acquisitions, platform build-outs, and growth situations that warrant scale beyond a single commitment, Pierpont accepts external funding from families, institutions, and operating partners whose horizon and standards match our own.
Participation is by relationship and invitation. We do not run a fund, we do not raise on a cycle, and we do not accept capital we would not put our own alongside. In every transaction, the family invests on the same terms as its partners.
Operating Companies
Pierpont maintains direct ownership and leadership roles in operating businesses, most prominently in healthcare, healthcare education, and workforce development. These are not passive positions. Where we own, we build.
Dr. LaPier serves as Chief Executive Officer of Cambridge Health. Pierpont’s corporate board commitments extend across Cambridge Health, Cambridge Education, Wellington Services, Wellington Investors and Pierpont Ventures.
Confidential Advisory and Corporate Growth
On a selective and confidential basis, Pierpont advises founders, chief executives, boards, and institutions on growth strategy, value creation, and the practical work of turning a vision into an operating reality. These engagements are limited by design and accepted where the relationship — not the fee — is the reason.
Pierpont is not a solo practice, and an assignment is not staffed with whoever is available. The office maintains a standing bench of Senior Advisors and a wider circle of external professionals, and each engagement is assembled deliberately against its focal area rather than pushed through a fixed methodology.
Depending on what the situation requires, that bench is drawn from operating executives with direct P&L accountability in the relevant industry, including at divisional scale inside large companies, and from transaction professionals experienced in roll-ups, management buyouts, joint ventures, alliances, and IPO positioning. It includes analytics and data specialists who treat data as a strategic capability rather than a technology purchase, and authorities in marketing, finance, and corporate development.
Where an assignment crosses borders, the office turns to international executives who can read the potential and the pitfalls in a specific region or sector quickly. Where it touches healthcare, healthcare education, or workforce development, it draws specialists from Pierpont’s own operating companies. And for board, trustee, and institutional assignments, it brings in governance and nonprofit leadership advisors.
Much of the most consequential work Pierpont does is never named.
Engagements are frequently sensitive and are treated accordingly — assignments with chief executives and boards where the value of the relationship is precisely that it is not discussed. What can be said publicly is that the work is confidential by default, that the team is built to fit rather than sold as a package, and that clients tend to return. Pierpont brings in its Senior Advisors often and are immersed within many assignments.
Pierpont invests its own capital first, and welcomes aligned external funding for strategic acquisitions and growth.
Pierpont’s philanthropy is not confined to writing checks, and the office’s most useful contribution to a nonprofit is often not money at all. It is the same expertise the office sells to companies, given away.
Mission-driven organizations face the same structural problems as growth companies and usually with less capacity to solve them: a strategy that has outrun its operating model, a board that needs sharpening, a revenue base concentrated in too few hands, a leadership succession nobody has planned, a merger or affiliation that would strengthen both parties if anyone knew how to structure it. These are Pierpont’s problems. The office works them for nonprofits on the same terms it works them for portfolio companies, and does so continuously rather than seasonally.
That work takes several forms. The first is trusteeship and board service, where the contribution is judgment exercised over years rather than advice delivered once. Alongside it, the office provides strategy and growth counsel to executive directors and presidents, given confidentially and without fee, and takes on governance and succession work — building boards that can govern, and planning leadership transitions before they become emergencies.
The office also provides direct financial support, concentrated in Catholic higher education, healthcare, nursing, and the formation of young leaders, and extends the Wharton practice of teaching and mentorship to students, young entrepreneurs, and early-career executives. Finally, it offers access: introductions from a network built over three decades, made available to institutions that could not otherwise reach it.